Grupo para el Estudio de la Salud Cardiometabólica (GESCAMET)
Group for the Study of Cardiometabolic Health
Our purpose is to understand pathophysiological mechanisms in cardiovascular disease (CVD) aimed at evaluating new drugs and designing new intervention strategies to prevent and/or slow the progression of CVD associated with overweight and obesity, as well as chronic kidney disease.
Our basic research is focused on the relationship between excess adipose tissue and the development of CVD, as well as in characterizing some of the molecular mechanisms involved in their development. We have a particular interest in the study of the influence of perivascular adipose tissue, as a source of paracrine factors, on vascular function and structure.
With a translational perspective, we are also interested in investigating and fostering community pharmacist´s intervention, delivered as a combination of health education, nutritional follow-up, and modification of life style habits, to prevent and/or reduce metabolic alterations associated with obesity.
If you want to go fast, go alone; if you want to go far, go in company.
Horizon 2020


-
Members
-
Research lines and methods
-
Publications
-
Projects
-
Innovation and transfer in drug research
-
Participation in European Networks
-
MINDSHIFT-MARIE Sklodowska-CURIE ACTIONS Innovative Training Network (ID 954798)
-
VascAgeNet - COST Action European Cooperation Science and Technology (ID 18216)
-
Reunión del proyecto europeo TOGETHER en el Instituto Pluridisciplinar
Los
días 10 y 11 de abril de 2026 se celebró en el Instituto Pluridisciplinar la reunión del proyecto europeo TOGETHER, enmarcado en la iniciativa THCS (Transforming Health and Care Systems) del programa Horizon Europe.
El proyecto tiene como objetivo mejorar el control de la hipertensión arterial mediante un modelo colaborativo entre atención primaria y farmacias comunitarias, promoviendo la detección precoz, la educación del paciente y el seguimiento integrado. En este contexto, el proyecto evalúa estrategias innovadoras como el uso del concepto de edad vascular y el empoderamiento del paciente para optimizar la adherencia y el control de la presión arterial.
Nota de prensa: https://semergen.es/index.php?seccion=sociedad&subSeccion=detalleNoticia&idN=3041
-
-
Collaborations
-
Dissemination and press releases